Skip to main content
Erschienen in: Breast Cancer Research and Treatment 3/2017

29.03.2017 | Epidemiology

Is breast compression associated with breast cancer detection and other early performance measures in a population-based breast cancer screening program?

verfasst von: Nataliia Moshina, Sofie Sebuødegård, Solveig Hofvind

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We aimed to investigate early performance measures in a population-based breast cancer screening program stratified by compression force and pressure at the time of mammographic screening examination. Early performance measures included recall rate, rates of screen-detected and interval breast cancers, positive predictive value of recall (PPV), sensitivity, specificity, and histopathologic characteristics of screen-detected and interval breast cancers.

Methods

Information on 261,641 mammographic examinations from 93,444 subsequently screened women was used for analyses. The study period was 2007–2015. Compression force and pressure were categorized using tertiles as low, medium, or high. χ 2 test, t tests, and test for trend were used to examine differences between early performance measures across categories of compression force and pressure. We applied generalized estimating equations to identify the odds ratios (OR) of screen-detected or interval breast cancer associated with compression force and pressure, adjusting for fibroglandular and/or breast volume and age.

Results

The recall rate decreased, while PPV and specificity increased with increasing compression force (p for trend <0.05 for all). The recall rate increased, while rate of screen-detected cancer, PPV, sensitivity, and specificity decreased with increasing compression pressure (p for trend <0.05 for all). High compression pressure was associated with higher odds of interval breast cancer compared with low compression pressure (1.89; 95% CI 1.43–2.48).

Conclusions

High compression force and low compression pressure were associated with more favorable early performance measures in the screening program.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Perry N, Broeders M, de Wolf C, Tornberg S, Holland R, von Karsa L (2006) European guidelines for quality assurance in breast cancer screening and diagnosis, 4th edn. European Communities, Luxemburg Perry N, Broeders M, de Wolf C, Tornberg S, Holland R, von Karsa L (2006) European guidelines for quality assurance in breast cancer screening and diagnosis, 4th edn. European Communities, Luxemburg
4.
Zurück zum Zitat Kopans DB (2006) Mammography and the normal breast imaging. Lippincott Williams & Wilkins, London, pp 357–363 Kopans DB (2006) Mammography and the normal breast imaging. Lippincott Williams & Wilkins, London, pp 357–363
5.
Zurück zum Zitat Yaffe MJ (2010) Basic physics of digital mammography. In: Bick U, Diekmann F (eds) Digital mammography. Springer, Berlin, pp 1–11CrossRef Yaffe MJ (2010) Basic physics of digital mammography. In: Bick U, Diekmann F (eds) Digital mammography. Springer, Berlin, pp 1–11CrossRef
6.
Zurück zum Zitat Poulos A, Rickard M (1997) Compression in mammography and the perception of discomfort. Australas Radiol 41:247–252CrossRefPubMed Poulos A, Rickard M (1997) Compression in mammography and the perception of discomfort. Australas Radiol 41:247–252CrossRefPubMed
7.
11.
Zurück zum Zitat de Groot JE, Broeders MJ, Branderhorst W, den Heeten GJ, Grimbergen CA (2013) A novel approach to mammographic breast compression: improved standardization and reduced discomfort by controlling pressure instead of force. Med Phys 40:081901. doi:10.1118/1.4812418 CrossRefPubMed de Groot JE, Broeders MJ, Branderhorst W, den Heeten GJ, Grimbergen CA (2013) A novel approach to mammographic breast compression: improved standardization and reduced discomfort by controlling pressure instead of force. Med Phys 40:081901. doi:10.​1118/​1.​4812418 CrossRefPubMed
14.
Zurück zum Zitat Holland K, Sechopoulos I, den Heeten G, Mann RM, Karssemeijer N (2016) Performance of Breast Cancer Screening Depends on Mammographic Compression. In: Tingberg A, Lång K, Timberg P (eds) Breast imaging: 13th international workshop, IWDM 2016, Malmö, Sweden, June 19–22, 2016, proceedings. Springer, Cham, pp 183–189 Holland K, Sechopoulos I, den Heeten G, Mann RM, Karssemeijer N (2016) Performance of Breast Cancer Screening Depends on Mammographic Compression. In: Tingberg A, Lång K, Timberg P (eds) Breast imaging: 13th international workshop, IWDM 2016, Malmö, Sweden, June 19–22, 2016, proceedings. Springer, Cham, pp 183–189
18.
Zurück zum Zitat Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19:403–410CrossRefPubMed Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19:403–410CrossRefPubMed
19.
Zurück zum Zitat Zeger SL, Liang KY (1992) An overview of methods for the analysis of longitudinal data. Stat Med 11:1825–1839CrossRefPubMed Zeger SL, Liang KY (1992) An overview of methods for the analysis of longitudinal data. Stat Med 11:1825–1839CrossRefPubMed
21.
Zurück zum Zitat Helvie MA, Chan HP, Adler DD, Boyd PG (1994) Breast thickness in routine mammograms: effect on image quality and radiation dose. Am J Roentgenol 163:1371–1374CrossRef Helvie MA, Chan HP, Adler DD, Boyd PG (1994) Breast thickness in routine mammograms: effect on image quality and radiation dose. Am J Roentgenol 163:1371–1374CrossRef
22.
Zurück zum Zitat Poulos A, McLean D, Rickard M, Heard R (2003) Breast compression in mammography: how much is enough? Australas Radiol 47:121–126CrossRefPubMed Poulos A, McLean D, Rickard M, Heard R (2003) Breast compression in mammography: how much is enough? Australas Radiol 47:121–126CrossRefPubMed
24.
26.
Zurück zum Zitat Romsdahl MM, McGrath RG, Hoppe E, McGrew EA (1965) Experimental model for the study of tumor cells in the blood. Acta Cytol 9:141–145PubMed Romsdahl MM, McGrath RG, Hoppe E, McGrew EA (1965) Experimental model for the study of tumor cells in the blood. Acta Cytol 9:141–145PubMed
27.
Zurück zum Zitat Watmough DJ, Quan KM, Aspden RM, Mallard JR (1992) Study of tissue compression in breast phantoms: possible implications for the use of X-ray mammography as a method of imaging breast carcinoma. Eur J Surg Oncol 18:538–544PubMed Watmough DJ, Quan KM, Aspden RM, Mallard JR (1992) Study of tissue compression in breast phantoms: possible implications for the use of X-ray mammography as a method of imaging breast carcinoma. Eur J Surg Oncol 18:538–544PubMed
28.
Zurück zum Zitat Watmough DJ, Quan KM, Aspden RM (1992) Unfavorable outcome of recent breast cancer screening trials: why? AJR Am J Roentgenol 159:1125–1126CrossRefPubMed Watmough DJ, Quan KM, Aspden RM (1992) Unfavorable outcome of recent breast cancer screening trials: why? AJR Am J Roentgenol 159:1125–1126CrossRefPubMed
29.
Zurück zum Zitat Watmough DJ, Quan KM, Aspden RM (1993) Breast compression: a preliminary study. J Biomed Eng 15:121–126CrossRefPubMed Watmough DJ, Quan KM, Aspden RM (1993) Breast compression: a preliminary study. J Biomed Eng 15:121–126CrossRefPubMed
32.
33.
Zurück zum Zitat Eklund GW, Cardenosa G, Parsons W (1994) Assessing adequacy of mammographic image quality. Radiology 190:297–307CrossRefPubMed Eklund GW, Cardenosa G, Parsons W (1994) Assessing adequacy of mammographic image quality. Radiology 190:297–307CrossRefPubMed
Metadaten
Titel
Is breast compression associated with breast cancer detection and other early performance measures in a population-based breast cancer screening program?
verfasst von
Nataliia Moshina
Sofie Sebuødegård
Solveig Hofvind
Publikationsdatum
29.03.2017
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 3/2017
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-017-4214-8

Weitere Artikel der Ausgabe 3/2017

Breast Cancer Research and Treatment 3/2017 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.